TSS
GTBP icon

Two Sigma Securities’s GT Biopharma GTBP Stock Holding History

Two Sigma Securities’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55K Sell
535
-737
-58% -$7.47K ﹤0.01% 1580
2026
Q1 		$13K Buy
1,272
+771
+154% +$10.5K ﹤0.01% 1440
2025
Q4 		$9.84K Sell
501
-182
-27% -$3.23K ﹤0.01% 1291
2025
Q3 		$10K Buy
+683
New +$25.5K ﹤0.01% 1217
2024
Q1 		– Sell
-50
Closed -$9.48K – 3211
2023
Q4 		$9.48K Buy
50
+9
+22% +$1.64K ﹤0.01% 2823
2023
Q3 		$7.46K Buy
+41
New +$8.47K ﹤0.01% 2741

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Arax Advisory Partners
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $479M AUM 15.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM

Two Sigma Securities's GTBP Position: Q2 2026 in Review

Two Sigma Securities reduced its GT Biopharma (GTBP) stake by 58% in Q2 2026, selling an estimated $7.47K and leaving 535 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Two Sigma Securities first reported a position in GTBP in Q3 2023 and has held it in 6 quarters since. The position peaked at $13K in Q1 2026. 55 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Two Sigma Securities held 535 shares of GT Biopharma worth $6.55K as of Q2 2026.
  • Two Sigma Securities sold 737 GT Biopharma shares in Q2 2026, an estimated $7.47K.
  • GT Biopharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1580 holding.
  • Two Sigma Securities first reported a position in GT Biopharma in Q3 2023 and has held it in 6 quarters since.
  • Two Sigma Securities's GT Biopharma position peaked at $13K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.